Doruk Erkan MD

Professor of Medicine, Weill Cornell Medicine

535 East 70th StreetNew York, NY 10021

Dr. Erkan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Erkan's full profile Already have an account?

Summary

Dr. Doruk Erkan, based in New York, specializes in rheumatology with a focus on Antiphospholipid Syndrome and Systemic Lupus Erythematosus. He completed his internal medicine residency at Icahn School of Medicine at Mount Sinai/Beth Israel from 1995 to 1998, following his medical degree from Hacettepe University.

Education & Training

Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 1995 - 1998
Hacettepe University FOMClass of 1995

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

NY State Medical License 2001 - 2027
FL State Medical License 2012 - 2014
American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2017
Fellow (FACR) American College of Rheumatology

Clinical Trials

A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome Start of enrollment: 2007 Sep 01
Completed
Phase 2
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients Start of enrollment: 2008 May 01
Completed
Phase 2
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) Start of enrollment: 2010 Sep 01
Completed

Publications & Presentations

PubMed

Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with aPLs: an APS ACTION Registry study.
Ibrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, Vittorio Pengo, Diana Parades-Ruiz
Rheumatology. 2026-06-30
Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.
Ecem Sevim, Zeynep B Erton, Doruk Erkan
Current Opinion in Immunology. 2026-06-01
1 citations
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refine...
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, Mary-Carmen Amigo, Danieli Andrade
Arthritis Care & Research. 2026-05-01

Journal Articles

Factors Associated with First Thrombosis in Patients Presenting with Obstetric Antiphospholipid Syndrome in APS Alliance for Clinical Trials & International Networking...
Doruk Erkan, Michelle Petri, H Michael Belmont, Jason S Knight, BJOG: An International Journal of Obstetrics & Gynaecology

Lectures

New Diagnostic and Treatment Strategies for Antiphospholipid Syndrome
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Other

McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome
Doruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-07-26
McMaster RARE‐Bestpractices Clinical Practice Guideline on Diagnosis and Management of the Catastrophic Antiphospholipid Syndrome
Doruk Erkan, MD, Journal of Thrombosis and Haemostasis
https://www.doximity.com/articles/8ab28beb-5bfe-44a8-acbc-c9ce9270ef68
UpToDate, Wolters Kluwer Health - 2012-08-13

Press Mentions

Novel Anti-NET Antibodies in a Multinational CohortMarch 28th, 2023
Updates on the ACR/EULAR Antiphospholipid SyndromeDecember 12th, 2022
Exagen Inc. Announces a Collaboration with Hospital for Special Surgery (HSS) for Antiphospholipid SyndromeAugust 3rd, 2020